| P50 | author | Peter Lundbäck | Q37374997 |
| | Ulf Andersson | Q37375023 |
| | Karin Palmblad | Q58739051 |
| P2093 | author name string | Hanna Schierbeck | |
| | Helena Erlandsson-Harris | |
| | Lars Ottosson | |
| | Lena Klevenvall | |
| P2860 | cites work | A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release | Q24321082 |
| | The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway | Q24538824 |
| | Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products | Q28116270 |
| | Release of chromatin protein HMGB1 by necrotic cells triggers inflammation | Q28131815 |
| | Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation | Q28262320 |
| | The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system | Q28567291 |
| | High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes | Q28574795 |
| | Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA | Q28587147 |
| | Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion | Q33193752 |
| | Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritis. | Q35869016 |
| | HMGB1 is a therapeutic target for sterile inflammation and infection | Q35953553 |
| | Role of HMGB1 in apoptosis-mediated sepsis lethality | Q36228722 |
| | High-mobility group box proteins modulate tumor necrosis factor-alpha expression in osteoclastogenesis via a novel deoxyribonucleic acid sequence | Q36629269 |
| | Utility of animal models for identification of potential therapeutics for rheumatoid arthritis | Q37022699 |
| | Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis | Q38274480 |
| | HMGB1-secreting capacity of multiple cell lineages revealed by a novel HMGB1 ELISPOT assay | Q40230862 |
| | HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. | Q40249835 |
| | The extracellular release of HMGB1 during apoptotic cell death | Q40253423 |
| | High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. | Q41080193 |
| | HMGB1 regulates RANKL-induced osteoclastogenesis in a manner dependent on RAGE. | Q41933401 |
| | Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis | Q46401884 |
| | Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels | Q46829587 |
| | High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis | Q47850293 |
| | Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats | Q48106802 |
| | HMGB1 is a bone-active cytokine. | Q53530203 |
| | TLR4 mediates early graft failure after intraportal islet transplantation. | Q54419154 |
| | High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis | Q58876474 |
| | Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages | Q59062762 |
| | Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases | Q59084980 |
| | Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity | Q60692920 |
| | Protective targeting of high mobility group box chromosomal protein 1 in a spontaneous arthritis model | Q60746248 |
| | Activation of gene expression in human neutrophils by high mobility group box 1 protein | Q73087842 |
| | High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine | Q73249056 |
| P433 | issue | 9-10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 1039-1044 | |
| P577 | publication date | 2011-06-07 | |
| P1433 | published in | Molecular Medicine | Q6895961 |
| P1476 | title | Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models | |
| P478 | volume | 17 | |